Phuket’s new public health chief arrives
Phuket’s new public health chief arrives
PHUKET: Dr Kusak Kukiattikoon arrived in Phuket today (Mar 8) to officially begin his duties as the new Chief of the Phuket Provincial Public Health Office (PPHO).
Monday 8 March 2021, 06:00PM
New Phuket Provincial Health Office Chief Dr Kusak Kukiattikoon arrived in Phuket today (Mar 8). Photo: PPHO
New Phuket Provincial Health Office Chief Dr Kusak Kukiattikoon arrived in Phuket today (Mar 8). Photo: PPHO
New Phuket Provincial Health Office Chief Dr Kusak Kukiattikoon arrived in Phuket today (Mar 8). Photo: PPHO
Several PPHO officers joined Dr Kusak in receiving their first COVID-19 vaccination injection today (Mar 8). Photo: PPHO
Monday, 08 March 2021 - 9:31
Ranitha Gnanarajah, a Sri Lankan lawyer and civil activist, has been included in this year s list of 14 International Courageous Women award presented annually by the US State Department.
On Monday, March 8, at 10:00 a.m., Secretary of State Antony J. Blinken will host the annual International Women of Courage (IWOC) Awards virtual ceremony to honor a group of extraordinary women from around the world, including an honorary award for seven women leaders and activists from Afghanistan who were assassinated for their dedication to improving the lives of Afghans.
The First Lady of the United States, Dr. Jill Biden will deliver remarks to recognize the courageous accomplishments of these women.
After Livongo sold to Teladoc last year, the company’s former president, Dr. Jennifer Schneider, is starting a new chapter on Cityblock’s board of directors. In an interview with MedCity News, she shared more about why she joined Cityblock and lessons learned during her time at Livongo.
Professional network of democratic teachers launched in Albania coe.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coe.int Daily Mail and Mail on Sunday newspapers.
FDA approval for Yescarta in follicular lymphoma makes it the first approved CAR-T treatment for this type of cancer. It also marks Gilead Sciences' third approved indication for a CAR-T cell therapy.